Endexx’s Skincare Products Expand in Mass Retail
CAVE CREEK, AZ, July 19, 2022 (GLOBE NEWSWIRE) -- via NewMediaWir – Endexx Corporation (OTCBB: EDXC) Endexx emphasizes becoming a competitive player in the premium Men’s Skincare and Grooming category. The new Blesswell™ Skincare line expands the opportunity to scale into mass retail without barriers of entry. This product set addresses a key market with price sensitivity and premium quality for Men truly seeking products that improve and support the health of their skin and hair grooming wellness.
With the expansion into select Target stores nationwide, Endexx is now in over 8000 Mass Retail stores in the US. While the economy is facing serious inflationary expansion, Endexx has been successful driving down production costs while offering consumers a high-quality product for daily use at a very affordable price.
Endexx CEO Todd Davis noted, “We are confident that “the Target Effect” will have a profound impact on the success and growth of our premium men’s skincare line.” Davis added, “Target historically provides affordably priced products of high quality and strong design to its customers. The Blesswell™ Men’s Skincare line uniquely fits into this product platform.”
Visit www.target.com and search for Blesswell or, https://www.target.com/s?searchTerm=blesswell&stof=true
Endexx highly recommends our customers and stakeholders to discover the value and experience our Blesswell™ Skincare products. Visit www.BlesswellSkincare.com to learn more.
For more information about Endexx Corporation:
Visit: www.endexx.com , www.cbdunlimited.com , www.blesswell.com , www.maggiesline.com , www.blesswell.co and www.blesswellskincare.com
About Endexx Corporation
Endexx Corporation, develops and distributes all-natural plant-derived topical skincare products. Its products vary from balms, creams, lotions, butters, masks, scrubs and oils all with the shared purpose of healthy skin and grooming wellness. The science behind these products involves a decade of clinical research in the field and lab work to provide functional formulation with ingredients for optimal absorption and the support of skin health.
Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995
We caution that any forward-looking statements (as such term is defined in the U.S. Private Securities Litigation Reform Act of 1995) contained in this press release or made by us, our management, or our spokespeople involve risks and uncertainties and are subject to change based on various factors, many of which are beyond our control.
Accordingly, our future performance and financial results may differ materially from those expressed or implied in any such forward-looking statements. Forward-looking statements include, without limitation, statements regarding our future operating results, the implementation and impact of our strategic plans, and our ability to meet environmental, social, and governance goals. Words such as “estimate,” “commit,” “target,” “goal,” “project,” “plan,” “believe,” “seek,” “strive,” “expect,” “anticipate,” “intend,” “potential” and any similar expressions may identify forward-looking statements. Risks associated with the following factors, among others, could affect our financial performance and cause actual results to differ materially from those expressed or implied in any forward-looking statements:
Except as may be required by law, we assume no obligation and do not intend to make publicly available any update or other revisions to any of the forward-looking statements contained in this press release to reflect circumstances existing after the date of this press release or to reflect the occurrence of future events, even if experience or future events make it clear that any expected results expressed or implied by those forward-looking statements will not be realized. More information on potential factors that could affect our results is included “Risk Factors” in our Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 31, 2022.
For further information, please contact:
Endexx Corporation
Endexx@endexx.com
480-595-6900
Attachment
